These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 15389235

  • 1. Extended follow-up of patients randomly assigned in the Angiotensin-converting enzyme inhibition Post-Revascularization Study (APRES).
    Kjøller-Hansen L, Steffensen R, Grande P.
    Am Heart J; 2004 Sep; 148(3):475-80. PubMed ID: 15389235
    [Abstract] [Full Text] [Related]

  • 2. Effect of ramipril in reducing sudden deaths and nonfatal cardiac arrests in high-risk individuals without heart failure or left ventricular dysfunction.
    Teo KK, Mitchell LB, Pogue J, Bosch J, Dagenais G, Yusuf S, HOPE Investigators.
    Circulation; 2004 Sep 14; 110(11):1413-7. PubMed ID: 15353497
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Long-term effects of ramipril on cardiovascular events and on diabetes: results of the HOPE study extension.
    Bosch J, Lonn E, Pogue J, Arnold JM, Dagenais GR, Yusuf S, HOPE/HOPE-TOO Study Investigators.
    Circulation; 2005 Aug 30; 112(9):1339-46. PubMed ID: 16129815
    [Abstract] [Full Text] [Related]

  • 5. Is angiotensin-converting enzyme inhibitor useful in a Japanese population for secondary prevention after acute myocardial infarction? A final report of the Japanese Acute Myocardial Infarction Prospective (JAMP) study.
    Ueshima K, Fukami K, Hiramori K, Hosoda S, Kishida H, Kato K, Fujita T, Tsutani K, Sakuma A, Japanese Acute Myocardial Infarction Prospective study group.
    Am Heart J; 2004 Aug 30; 148(2):e8. PubMed ID: 15309011
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of ramipril on postrevascularization prevalence of angina and quality of life.
    Kjøller-Hansen L, Steffensen R, Grande P.
    Int J Cardiol; 2004 Jun 30; 95(2-3):159-65. PubMed ID: 15193814
    [Abstract] [Full Text] [Related]

  • 8. Angiotensin-converting enzyme inhibitors in patients with coronary artery disease and absence of heart failure or left ventricular systolic dysfunction: an overview of long-term randomized controlled trials.
    Danchin N, Cucherat M, Thuillez C, Durand E, Kadri Z, Steg PG.
    Arch Intern Med; 2006 Apr 10; 166(7):787-96. PubMed ID: 16606817
    [Abstract] [Full Text] [Related]

  • 9. The prognostic significance of bundle branch block in high-risk chronic stable vascular disease patients: a report from the HOPE trial.
    Sumner G, Salehian O, Yi Q, Healey J, Mathew J, Al-Merri K, Al-Nemer K, Mann JF, Dagenais G, Lonn E, HOPE Investigators.
    J Cardiovasc Electrophysiol; 2009 Jul 10; 20(7):781-7. PubMed ID: 19298567
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of ramipril on morbidity and mode of death among survivors of acute myocardial infarction with clinical evidence of heart failure. A report from the AIRE Study Investigators.
    Cleland JG, Erhardt L, Murray G, Hall AS, Ball SG.
    Eur Heart J; 1997 Jan 10; 18(1):41-51. PubMed ID: 9049514
    [Abstract] [Full Text] [Related]

  • 12. Tissue ACE inhibitors for secondary prevention of cardiovascular disease in patients with preserved left ventricular function: a pooled meta-analysis of randomized placebo-controlled trials.
    Saha SA, Molnar J, Arora RR.
    J Cardiovasc Pharmacol Ther; 2007 Sep 10; 12(3):192-204. PubMed ID: 17875946
    [Abstract] [Full Text] [Related]

  • 13. Effects of angiotensin-converting enzyme inhibition in low-risk patients early after coronary artery bypass surgery.
    Rouleau JL, Warnica WJ, Baillot R, Block PJ, Chocron S, Johnstone D, Myers MG, Calciu CD, Dalle-Ave S, Martineau P, Mormont C, van Gilst WH, IMAGINE (Ischemia Management with Accupril post-bypass Graft via Inhibition of the coNverting Enzyme) Investigators.
    Circulation; 2008 Jan 01; 117(1):24-31. PubMed ID: 18071079
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Rationale, characteristics and study design of PREAMI (Perindopril and Remodelling in the Elderly with Acute Myocardial Infraction)].
    Magrini G, Nicolosi GL, Chiariello M, Ferrari R, Remme P, Tavazzi L.
    Ital Heart J; 2005 Nov 01; 6 Suppl 7():14S-23S. PubMed ID: 16485513
    [Abstract] [Full Text] [Related]

  • 16. Long-term effects of quinapril with high affinity for tissue angiotensin-converting enzyme after coronary intervention in Japanese.
    Otsuka M, Yamamoto H, Okimoto T, Dohi Y, Mito S, Gomyo Y, Fujii T, Matsuura W, Hirai Y, Kohno N.
    Am Heart J; 2004 Apr 01; 147(4):662-8. PubMed ID: 15077082
    [Abstract] [Full Text] [Related]

  • 17. Effects of angiotensin-converting enzyme inhibition with perindopril on left ventricular remodeling and clinical outcome: results of the randomized Perindopril and Remodeling in Elderly with Acute Myocardial Infarction (PREAMI) Study.
    Ferrari R, Perindopril and Remodeling in Elderly with Acute Myocardial Infarction Investigators.
    Arch Intern Med; 2006 Mar 27; 166(6):659-66. PubMed ID: 16567606
    [Abstract] [Full Text] [Related]

  • 18. Antecedent hypertension and the effect of captopril on the risk of adverse cardiovascular outcomes after acute myocardial infarction with left ventricular systolic dysfunction: Insights from the Survival and Ventricular Enlargement Trial.
    Kenchaiah S, Davis BR, Braunwald E, Rouleau JL, Dagenais GR, Sussex B, Steingart RM, Brown EJ, Lamas GA, Gordon D, Bernstein V, Pfeffer MA, Survival and Ventricular Enlargement Trial.
    Am Heart J; 2004 Aug 27; 148(2):356-64. PubMed ID: 15309009
    [Abstract] [Full Text] [Related]

  • 19. Prognostic factors affecting the all-cause death and sudden cardiac death rates of post myocardial infarction patients with low left ventricular ejection fraction.
    Dai SM, Zhang S, Chen KP, Hua W, Wang FZ, Chen X.
    Chin Med J (Engl); 2009 Apr 05; 122(7):802-6. PubMed ID: 19493393
    [Abstract] [Full Text] [Related]

  • 20. Angiotensin-converting enzyme inhibition limits dysfunction in adjacent noninfarcted regions during left ventricular remodeling.
    Kramer CM, Ferrari VA, Rogers WJ, Theobald TM, Nance ML, Axel L, Reichek N.
    J Am Coll Cardiol; 1996 Jan 05; 27(1):211-7. PubMed ID: 8522697
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.